Rodriguez-Arellano, J
Disclosure of interest: nothing to disclose Scientific Communications: risk factors 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.03 - EPIDEMIOLOGY & RISK FACTORS O - ESOC25-2033 CLINICAL CHARACTERISTICS ASSOCIATED WITH NOT USING ORAL ANTICOAGULANTS AT THE TIME OF FIRST ISCHEMIC STROKE IN PATIENTS WITH ATRIAL FIBRILLATION: A NATIONWIDE STUDY Marko Vilpponen 1 , Jukka Putaala 2 , Aapo Aro 3 , Mika Lehto 4 , Olli Halminen 5 , Paula Tiili 6 , Miika Linna 5 , Alex Luojus 7 , Konsta Teppo 8 , Pirjo Mustonen 8 , Jari Haukka 9 , Juha Hartikainen 10 , Juhani Airaksinen 8 1 University of Helsinki, Helsinki, Finland, 2 Department of Neurology, Helsinki University Hospital and University of Helsinki, Finland, Helsinki, Finland, 3 Heart and Lung Center, Helsinki University Hospital and University of Helsinki, Finland, Helsinki, Finland, 4 Department of Internal Medicine, Jorvi Hospital and Helsinki University Hospital, Espoo, Finland and University of Helsinki, Finland, Espoo, Helsinki, Finland, 5 Department of Industrial Engineering and Management, Aalto University, Espoo, Finland, Helsinki, Finland, 6 Primary Health Care Unit, Helsinki University Hospital, Helsinki, Finland, Helsinki, Finland, 7 University of Helsinki, Finland;, Helsinki, Finland, 8 Heart Center, Turku University Hospital and University of Turku, Finland, Turku, Finland, 9 Department of Public Health, University of Helsinki, Finland, Helsinki, Finland, 10 Heart Center, Kuopio University Hospital and University of Eastern Finland, Kuopio, Finland, Kuopio, Finland Background and Aims: This study identifies the characteristics of AF (atrial fibrillation) patients at the time of their first IS (ischemic stroke) episode who were not on OAC (oral anticoagulation) therapy
At Christchurch Clinics, were here to support your health with safe, effective treatment.
PAM) pathways are two signaling pathways that are necessary for many cellular activities, such as motility, proliferation, differentiation, metabolism, survival, and angiogenesis, in both normal physiology and development of cancer [75]
